Realm Therapeutics - Block listing Interim Review

February 18, 2019
window.NREUM||(NREUM={}); = {"beacon":"","errorBeacon":"","licenseKey":"6415801d43","applicationID":"186842935","transactionName":"NVFUYEIHWkEDARFRXgwbd2dgSU9EBxAWUV4MSRlPUwpdVwwWLHxMTXlXRlsDQB0sBxJLHhl9ckkfJFtWG00eW14MQFNaRC9wTw==","queueTime":0,"applicationTime":12,"agent":"","atts":""}window.NREUM||(NREUM={}),__nr_require=function(e,n,t){function r(t){if(!n[t]){var o=n[t]={exports:{}};e[t][0].call(o.exports,function(n){var o=e[t][1][n];return r(o||n)},o,o.exports)}return n[t].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o var w=window;if(w.performance||w.mozPerformance||w.msPerformance||w.webkitPerformance){var d=document;AKSB=w.AKSB||{},AKSB.q=AKSB.q||[],AKSB.mark=AKSB.mark||function(e,_){AKSB.q.push(["mark",e,_||(new Date).getTime()])},AKSB.measure=AKSB.measure||function(e,_,t){AKSB.q.push(["measure",e,_,t||(new Date).getTime()])},AKSB.done=AKSB.done||function(e){AKSB.q.push(["done",e])},AKSB.mark("firstbyte",(new Date).getTime()),{custid:"793678",ustr:"",originlat:"0",clientrtt:"1",ghostip:"",ipv6:false,pct:"10",clientip:"",requestid:"a3300b0b",region:"26162",protocol:"",blver:14,akM:"a",akN:"ae",akTT:"O",akTX:"1",akTI:"a3300b0b",ai:"501146",ra:"false",pmgn:"",pmgi:"",pmp:"",qc:""},function(e){var _=d.createElement("script");_.async="async",_.src=e;var t=d.getElementsByTagName("script"),t=t[t.length-1];t.parentNode.insertBefore(_,t)}(("https:"===d.location.protocol?"https:":"http:")+"//")}
RNS Number : 2001Q
Realm Therapeutics PLC
18 February 2019

Realm Therapeutics plc

Block Listing Interim Review


Pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies Realm Therapeutics plc makes the following update on its block listing:


Date: 18 February 2019


Name of applicant:

Realm Therapeutics plc

Name of scheme:

Executive Omnibus Incentive Plan


Figures for all schemes relate to ordinary shares

of 10 pence each

Period of return:

From: 18 August 2018 To: 15 February 2019

Balance of unallotted securities under scheme(s) from previous return:



Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):



Less:  Number of securities issued/allotted under scheme(s) during period:



Equals:  Balance under scheme(s) not yet issued/allotted at end of period:





Number and class of securities originally admitted:


* these securities have been adjusted for a 1 for 10 share consolidation which took effect on 2 July 2010

*20,000 and

*378,423 + *32,000 and 200,000

*196,087 and


Dates of Admission:


7 August 2006 and 31 August 2007 and 15 August 2012

7 August 2006 and

31 August 2007

Name of contact:

Marella Thorell, Company Secretary

Telephone number of contact:

+1 484-321-2749


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

Search Investor Relations